Product
Symbiter-Omega
1 clinical trial
5 indications
Indication
ObesityIndication
Insulin ResistanceIndication
Insulin SensitivityIndication
Type 2 DiabetesIndication
Visceral ObesityClinical trial
Probiotic With Omega-3 Fatty Acids on Obesity and Insulin Resistance Management in Patients With Type 2 DiabetesStatus: Completed, Estimated PCD: 2018-03-01